Consultant Clinical Oncologist
Professor David Dodwell is a Consultant Clinical Oncologist at Leeds Teaching Hospitals Trust where he specialises in the treatment of breast cancer using chemotherapy and radiotherapy.
He has held a Visiting Professorship to Sheffield Hallam University since 2004 and is heavily involved in research, policy development and clinical audit.
He is an active member of several professional organisations including the Royal College of Physicians, the British Medical Association, the British Oncological Association, the Association of Cancer Physicians and the British Breast Group.
Professor Dodwell’s research interests include adjuvant cytotoxic, endocrine and radio therapeutic interventions in breast cancer and the impact of loco-regional therapy on mortality. He is Chair of the Chemotherapy Clinical Information Group for the Systemic Anti-Cancer Therapy dataset which works to understand patterns of service provision and support clinical decision-making to improve patient care and outcomes.